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.1. Need for developing case denitions and guidelines for data
ollection, analysis, and presentation for non-reassuring fetal
tatus as an adverse event following immunization
Non-reassuring fetal status is a term used to describe suspected
etal hypoxia and is meant to replace the more ubiquitous term
fetal distress. Fetal distress, dened as progressive fetal hypoxia
nd/or acidemia secondary to inadequate fetal oxygenation, is a
erm that is used to indicate changes in fetal heart patterns, reduced
etal movement, fetal growth restriction, and presence of meco-
ium stained uid [1]. Although fetal distress may  be associated
 Corresponding author. Tel.: +1 919 681 5220.
E-mail address: contact@brightoncollaboration.org (C. Gravett).
1 Brighton Collaboration homepage: http://www.brightoncollaboration.org.
ttp://dx.doi.org/10.1016/j.vaccine.2016.03.043
264-410X/' 2016 Published by Elsevier Ltd. This is an open access article under the CC Bwith neonatal encephalopathy, the generic term has poor predic-
tive value for neonatal outcomes; most neonates will be vigorous
and healthy at birth despite a diagnosis of fetal distress. Fetal dis-
tress can only be observed indirectly, usually via electronic fetal
heart rate monitoring which is subject to high intra- and inter-
observer variability in data interpretation [24]. For this reason,
many experts recommend abandoning the term fetal distress, and
adopting the term non-reassuring fetal status to describe clinical
interpretation of fetal well-being [1,5,6]. Consistent with current
opinion in the eld, we recommend use of the term non-reassuring
fetal status for use in monitoring fetal response following
immunization.
Non-reassuring fetal status is not an adverse event per se,
but rather an indicator of an underlying condition resulting in
temporary or permanent oxygen deprivation to the fetus which
may  lead to fetal hypoxia and metabolic acidosis. Since fetal
oxygenation is dependent upon maternal oxygenation and pla-
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lood supply, placental transfer or fetal gas transport may  lead
o fetal hypoxia and non-reassuring fetal status [7]. Conditions
ommonly associated with non-reassuring fetal status include
aternal cardiovascular disease, anemia, diabetes, hypertension,
nfection, placental abruption, abnormal presentation of the fetus,
ntrauterine growth restriction and umbilical cord compression,
mong other obstetric, maternal or fetal conditions.
The fetus experiences three stages of deterioration when oxygen
evels are depleted: transient hypoxia without metabolic acido-
is, tissue hypoxia with a risk of metabolic acidosis, and hypoxia
ith metabolic acidosis [7,8]. Fetal response to oxygen depriva-
ion is regulated by the autonomous nervous system, mediated
y parasympathetic and sympathetic mechanisms. The fetus is
quipped with compensatory mechanisms for transient hypoxia
uring labor, but prolonged, uninterrupted fetal hypoxia may
ead progressively to acidosis with cell death, tissue damage,
rgan failure and potentially death. In response to hypoxia, fetal
ompensatory mechanisms include 1) a decrease in heart rate;
) a reduction in oxygen consumption secondary to cessation
f nonessential functions such as gross body movements; 3) a
edistribution of cardiac output to preferentially perfuse organs,
uch as the heart, brain, and adrenal glands; and 4) a switch
o anaerobic cellular metabolism [9]. Prolonged fetal hypoxia
s associated with signicant perinatal morbidity and mortality
ith particular concern for short- and long-term complications
ncluding encephalopathy, seizures, cerebral palsy, and neurode-
elopmental delay [10,11]. The fetal heart rate changes markedly
n response to prolonged oxygen deprivation, making fetal heart
ate monitoring a potentially valuable and commonly used tool for
ssessing fetal oxygenation status in real time. Non-reassuring fetal
eart rate patterns are observed in approximately 15% of labors
12].
The two most common methods of monitoring fetal heart
ate are cardiotocography (CTG) and intermittent auscultation.
n high resource settings, continuous electronic fetal heart rate
onitoring, via cardiotocography is the most prevalent method.
ontinuous CTG involves monitoring the fetal heart rate and uter-
ne contractility simultaneously to detect fetal heart rate patterns
ssociated with decient fetal oxygen supply [8]. Normal CTG trac-
ngs are characterized by 1) stable baseline fetal heart rate (FHR)
f 120160 beats per minute (bpm), 2) FHR variability between 5
nd 25 bpm above and below baseline FHR, and 3) periodic changes
n the baseline FHR (accelerations above baseline or decelerations
elow baseline) [13]. While accelerations are associated with fetal
ell-being, decelerations, especially prolonged bradycardia, late
ecelerations, and severe variable decelerations are indicative of
etal stress and should prompt the clinician to evaluate and initi-
te intrauterine resuscitation with consideration for delivery of the
etus as indicated. Abnormal fetal heart rate patterns have high sen-
itivity, but low specicity and low predictive value to discriminate
etween neonates with or without metabolic acidosis [14]. While a
ormal fetal heart rate pattern is usually indicates reassuring fetal
tatus, an abnormal fetal heart rate pattern does not necessarily
quate with hypoxia or acidosis.
Although continuous CTG is the accepted standard of care in
ost high resource settings, use of continuous CTG in low resource
etting is not feasible or recommended [15]. Continuous CTG
equires costly equipment, expert maintenance, supply chain for
onsumables, and extensive training and high level of technical
kill to interpret tracings. Additionally, continuous CTG can lead
o higher rates of un-necessary interventions that may  pose addi-
ional risk to mothers in settings where safe cesarean delivery is
ot readily available [16].
In  settings where CTG is unavailable, intermittent auscultation is
ecommended for all laboring parturients [17]. Intermittent auscul-
ation (IA) involves assessing the fetal heart rate at predetermined 
intervals with either a fetal stethoscope, or handheld Doppler.
Abnormal heart rate ndings by IA indicative of non-reassuring
fetal status include prolonged fetal tachycardia or bradycardia,
presence of repetitive or prolonged decelerations, and uterine
tachysystole (more than 5 uterine contractions in a 10 min  period).
There is no evidence that IA performs worse than CTG in reduc-
ing morbidity and mortality associated with fetal acidosis. Studies
comparing CTG to IA show no reduction in the risk of perinatal death
or cerebral palsy [16,18]. Intermittent auscultation, characterized
by low cost and low technology equipment, is more feasible than
CTG in low resource settings. However, it requires a high level of
training and skill, frequent interaction between patient and health
care provider, and does not provide as sophisticated a level of infor-
mation that may  be needed in high risk populations.
Several efforts to develop standards for dening non-reassuring
fetal status have been made in response to confusion in recog-
nizing and managing fetal heart rate patterns indicative of fetal
compromise. The most widely accepted standards for classifying
non-reassuring fetal heart rates come from the National Institute
of Child Health and Human Development (NICHD) in the United
States and The International Federation of Gynecology and Obstet-
rics (FIGO) (Table 1). In 1997, NICHD convened a workshop with
the express purpose of developing a standardized and rigorously,
unambiguously described set of denitions to quantitate fetal heart
monitoring [19]. The workshop produced standardized nomencla-
ture for characterizing fetal heart rate patterns, which was  widely
adopted by western obstetric societies. In 2008, a follow-up work-
shop including the Society for Maternal Fetal Medicine and the
American College of Obstetricians and Gynecologists was con-
vened, resulting in the development of a three-tiered classication
system of fetal heart rate patterns to guide management of fetal
compromise [20,21]. The Working Group uses these guidelines as
a basis for the highest level of certainty for dening a case of non-
reassuring fetal status. The NICHD guidelines are limited in dening
fetal status in all settings as they are only intended for use with CTG.
A second important set of guidelines, more applicable to all sett-
ings was  rst introduced by FIGO in 1986 and was  updated in 2015
[17,2226]. The FIGO guidelines are the only guidelines with broad
international consensus, and are simplied, with less emphasis on
decelerations compared to the NICHD guidelines when evaluating
CTG tracings. FIGO also provides recommendations for evaluat-
ing and categorizing fetal heart rate via intermittent auscultation,
making these guidelines more useful for low resource settings.
When CTG is not available, the Working Group recommends incor-
porating heart rate patterns from IA into the case denition for
non-reassuring fetal status.
Little  is known about the relationships among non-reassuring
fetal status and maternal immunization, especially in LMIC where
fetal assessment may  not be routine. There are few publications
reporting on fetal status following immunization; those that do are
case reports or small series that have frequently not used stan-
dardized denitions [2729]. Possible reasons that immunization
surveillance has failed to report on cases of non-reassuring fetal
status include the fact that a causal relationship is rarely if ever
established, the low predictive value of non-reassuring fetal status
to predict adverse neonatal outcomes, the difculty of temporally
associating vaccination with fetal status, as the two events are likely
to be monitored at very different time-points in pregnancy, the
failure to include fetal status as an outcome variable in immuniza-
tion trials or surveillance. Estimates of the incidence of fetal status
following maternal immunization have been hampered by limited
data and lack of standard case denitions.
34 (2016) 6084–6092 6085Moving forward, uniform and standardized denitions for non-
reassuring fetal status and fetal well-being will be critical in
immunization trials surveillance and monitoring to insure data
comparability across trials. This is imperative to facilitate data
Table  1
Comparison of NICHD and FIGO guidelines for interpretation of fetal heart rate via continuous cardiotocography. FHR = fetal heart rate, bpm = beats per minute.
NICHD three-tier fetal heart rate interpretation system (2008) FIGO consensus guidelines on intrapartum fetal monitoring CTG tracing
classications (2015)
FHR designation Description FHR designation Description






Early decelerations may  be present or absent
Accelerations may  be present or absent






Category II tracing FHR tracing does not meet criteria for category I
or category III
Suspicious Lacking at least one characteristic of normality,
but with no pathologic features
Category III tracing 1) Variability:
Absent FHR baseline variability
AND any of the following:
Recurrent late decelerations
Recurrent variable decelerations
Bradycardia (FHR < 110 bpm)
OR
2) Sinusoidal pattern
Pathological Baseline heart rate:
<100 bpm
Variability:
Reduced variability for >15 min
Increased variability for >30 min
OR
Sinusoidal pattern for >30 min
Decelerations:
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vent.
.2. Methods for the development of the case denition and
uidelines for data collection, analysis, and presentation for
on-reassuring fetal status as an adverse events following
mmunization
Following the process described in the overview paper as
ell as on the Brighton Collaboration Website http://www.
rightoncollaboration.org/internet/en/index/process.html, the
righton Collaboration Fetal Distress Working Group was  formed in
015 and included members of clinical and academic, as well as
ublic health background. Members have experience in high and
ow resources settings. The composition of the working and refer-
nce group as well as results of the web-based survey completed
y the reference group with subsequent discussions in the working
roup can be viewed at: http://www.brightoncollaboration.org/
nternet/en/index/working groups.html.
To guide the decision-making for the case denition and guide-
ines, literature was searched using Medline, Embase and the
ochrane Libraries, including the terms vaccines, vaccination, or
mmunization (or terms beginning with vaccin-, immuni-, inocular-
 and non-reassuring fetal status, fetal distress, intrapartum fetal
sphyxia, non-reassuring fetal heart rate, fetal compromise, fetal
ypoxia, fetal intolerance of labor. To identify case denitions and
easures of fetal distress in all settings, the above search terms
ere also searched with the terms developing country or low
esource setting.  The search was limited to publications written in
nglish with human subjects. The search resulted in the identi-
ation of 105 references. All abstracts were screened for possible
eports of non-reassuring fetal status, or fetal distress, following
mmunization. Eighteen articles with potentially relevant material
ere reviewed in more detail, in order to identify studies using case
enitions or, in their absence, providing clinical descriptions of
he case material. This resulted in a detailed summary of 2 articles,
ncluding information on the study type, the vaccine, the diag-
ostic criteria or case denition put forth, the time interval since
mmunization, and other symptoms. Multiple general medical and
bstetric text books and obstetric society publications were also
earched.>30 min  or 20 min if reduced variability
OR
One prolonged deceleration with >5 min
Most publications were single case reports. The terminology and
case denitions were inconsistent among studies, with very few
reporting case denitions at all. An inventory comprising 5 relevant
case denitions of non-reassuring fetal status was made available
to working group members.
1.3. Rationale for selected decisions about the case denition of
non-reassuring fetal status as an adverse event following
immunization
1.3.1. The term non-reassuring fetal status
Several related terms are commonly used to describe fetal
status including fetal distress, birth asphyxia, and fetal intol-
erance to labor. The Working Group was  initially tasked with
developing a case denition for fetal distress, but for reasons
previously discussed, this term was abandoned and replaced with
non-reassuring fetal status. The Working Group chose not to use
the term fetal intolerance of labor because specifying such a nar-
row timeframe fails to capture non-reassuring fetal status in the
antepartum period prior to the onset of labor.
In developing a case denition for non-reassuring fetal status,
the Working Group included only cases for which fetal heart rate
can be ascertained. The inability to measure fetal heart rate does
not permit a diagnosis of non-reassuring fetal status at any accept-
able level of diagnostic certainty. Within the denition context,
however, the three diagnostic levels must not be misunderstood as
reecting different grades of clinical severity. They instead reect
diagnostic certainty (see below). All Levels are considered accept-
able depending on the availability of diagnostic tools in each site.
1.3.2. The term birth asphyxia
Birth asphyxia is often erroneously used interchangeably with
fetal distress. Birth asphyxia is dened as the failure of the
neonate to start regular respiration within one minute of birth,
resulting from progressive hypoxia leading to acidosis in utero.
Non-reassuring fetal status is distinct from birth asphyxia, as non-
reassuring fetal status may  be detected via fetal heart monitoring
as a response to fetal hypoxia long before acidosis or asyphxia
occur and will not necessarily result in birth asphyxia [5]. There-
fore, although non-reassuring fetal status may  be observed prior to
